Causal relationship between thyroid dysfunction and ovarian cancer: a two-sample Mendelian randomization study
View abstract on PubMed
Summary
This summary is machine-generated.This study used Mendelian randomization to investigate the causal link between thyroid dysfunction and ovarian cancer (OC) risk. Findings suggest hyperthyroidism may increase OC risk, offering insights for early prevention.
Area Of Science
- Endocrinology and Oncology
- Genetic Epidemiology
Background
- Observational studies suggest a link between thyroid dysfunction and increased ovarian cancer (OC) risk.
- The causal relationship between thyroid dysfunction and OC remains uncertain.
- Mendelian randomization (MR) can help elucidate potential causal effects.
Purpose Of The Study
- To investigate the causal impact of thyroid dysfunction on ovarian cancer (OC) risk using a Mendelian randomization (MR) study.
- To determine if genetic predisposition to thyroid dysfunction influences OC risk.
Main Methods
- Utilized genome-wide association study (GWAS) data for thyroid-related traits (TSH, FT4, hypothyroidism, hyperthyroidism) as exposures.
- Selected ovarian cancer (OC) data from a large cohort (N=199,741) as the outcome.
- Employed inverse variance-weighted (IVW) method and conducted sensitivity analyses to ensure result robustness.
Main Results
- A genetic predisposition to hyperthyroidism was associated with a potential increase in ovarian cancer (OC) risk (OR=1.094, p=0.004).
- No significant causal effect was found for hypothyroidism, TSH, or FT4 on OC risk.
- Sensitivity analyses confirmed the reliability of the findings, showing no significant heterogeneity or pleiotropy.
Conclusions
- This MR study provides evidence supporting a correlation between hyperthyroidism and increased ovarian cancer (OC) risk.
- Genetically predicted hyperthyroidism offers potential insights for early prevention and intervention strategies for OC.
Related Concept Videos
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

